Literature DB >> 29440349

Genetic tests in lymphatic vascular malformations and lymphedema.

Sandro Michelini1, Stefano Paolacci2, Elena Manara2, Costantino Eretta3, Raul Mattassi4, Byung-Boong Lee5, Matteo Bertelli2.   

Abstract

Syndromes with lymphatic malformations show phenotypic variability within the same entity, clinical features that overlap between different conditions and allelic as well as locus heterogeneity. The aim of this review is to provide a comprehensive clinical genetic description of lymphatic malformations and the techniques used for their diagnosis, and to propose a flowchart for genetic testing. Literature and database searches were performed to find conditions characterised by lymphatic malformations or the predisposition to lymphedema after surgery, to identify the associated genes and to find the guidelines and genetic tests currently used for the molecular diagnosis of these disorders. This search allowed us to identify several syndromes with lymphatic malformations that are characterised by a great heterogeneity of phenotypes, alleles and loci, and a high frequency of sporadic cases, which may be associated with somatic mutations. For these disorders, we found many diagnostic tests, an absence of harmonic guidelines for molecular diagnosis and well-established clinical guidelines. Targeted sequencing is the preferred method for the molecular diagnosis of lymphatic malformations. These techniques are easy to implement and have a good diagnostic success rates. In addition, they are relatively inexpensive and permit parallel analysis of all known disease-associated genes. The targeted sequencing approach has improved the diagnostic process, giving patients access to better treatment and, potentially, to therapy personalised to their genetic profiles. These new techniques will also facilitate the prenatal and early postnatal diagnosis of congenital lymphatic conditions and the possibility of early intervention. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  Genetic Test; Lymphatic Vascular Malformation; Lymphedema; Next Generation Sequencing; Somatic Variant

Mesh:

Year:  2018        PMID: 29440349     DOI: 10.1136/jmedgenet-2017-105064

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  11 in total

1.  [Differential diagnostics of lipedema and lymphedema : A practical guideline].

Authors:  U Wollina; B Heinig
Journal:  Hautarzt       Date:  2018-12       Impact factor: 0.751

2.  Low Efficacy of Genetic Tests for the Diagnosis of Primary Lymphedema Prompts Novel Insights into the Underlying Molecular Pathways.

Authors:  Gabriele Bonetti; Stefano Paolacci; Michele Samaja; Paolo Enrico Maltese; Sandro Michelini; Serena Michelini; Silvia Michelini; Maurizio Ricci; Marina Cestari; Astrit Dautaj; Maria Chiara Medori; Matteo Bertelli
Journal:  Int J Mol Sci       Date:  2022-07-03       Impact factor: 6.208

3.  Mutations in the ARAP3 Gene in Three Families with Primary Lymphedema Negative for Mutations in Known Lymphedema-Associated Genes.

Authors:  Maurizio Ricci; Rita Compagna; Bruno Amato; Sercan Kenanoglu; Dominika Veselenyiova; Danjela Kurti; Mirko Baglivo; Syed Hussain Basha; Roberta Serrani; Giacinto Abele Donato Miggiano; Barbara Aquilanti; Giuseppina Matera; Giuseppe Marceddu; Valeria Velluti; Lucilla Gagliardi; Munis Dundar; Juraj Krajcovic; Matteo Bertelli
Journal:  Int J Genomics       Date:  2020-08-25       Impact factor: 2.326

4.  [Differential diagnostics of lipedema and lymphedema : A practical guideline].

Authors:  U Wollina; B Heinig
Journal:  Z Rheumatol       Date:  2018-11       Impact factor: 1.372

Review 5.  The Role of Interventional Radiologists in the Treatment of Congenital Lymphatic Malformations.

Authors:  Julie Cronan; Anne E Gill; Jay H Shah; C Matthew Hawkins
Journal:  Semin Intervent Radiol       Date:  2020-07-31       Impact factor: 1.513

6.  TIE1 as a Candidate Gene for Lymphatic Malformations with or without Lymphedema.

Authors:  Sandro Michelini; Maurizio Ricci; Dominika Veselenyiova; Sercan Kenanoglu; Danjela Kurti; Mirko Baglivo; Alessandro Fiorentino; Syed Hussain Basha; Sasi Priya; Roberta Serrani; Juraj Krajcovic; Munis Dundar; Astrit Dautaj; Matteo Bertelli
Journal:  Int J Mol Sci       Date:  2020-09-16       Impact factor: 5.923

7.  Primary lymphedema French National Diagnosis and Care Protocol (PNDS; Protocole National de Diagnostic et de Soins).

Authors:  Stéphane Vignes; Juliette Albuisson; Laurence Champion; Joël Constans; Valérie Tauveron; Julie Malloizel; Isabelle Quéré; Laura Simon; Maria Arrault; Patrick Trévidic; Philippe Azria; Annabel Maruani
Journal:  Orphanet J Rare Dis       Date:  2021-01-06       Impact factor: 4.123

8.  Segregation Analysis of Rare NRP1 and NRP2 Variants in Families with Lymphedema.

Authors:  Sandro Michelini; Bruno Amato; Maurizio Ricci; Sercan Kenanoglu; Dominika Veselenyiova; Danjela Kurti; Mirko Baglivo; Elena Manara; Munis Dundar; Juraj Krajcovic; Syed Hussain Basha; Sasi Priya; Roberta Serrani; Giacinto A D Miggiano; Barbara Aquilanti; Giuseppina Matera; Valeria Velluti; Lucilla Gagliardi; Astrit Dautaj; Matteo Bertelli
Journal:  Genes (Basel)       Date:  2020-11-17       Impact factor: 4.096

9.  Two rare PROX1 variants in patients with lymphedema.

Authors:  Maurizio Ricci; Bruno Amato; Shila Barati; Rita Compagna; Dominika Veselenyiova; Sercan Kenanoglu; Liborio Stuppia; Tommaso Beccari; Mirko Baglivo; Danjela Kurti; Juraj Krajcovic; Roberta Serrani; Munis Dundar; Syed H Basha; Pietro Chiurazzi; Matteo Bertelli
Journal:  Mol Genet Genomic Med       Date:  2020-08-05       Impact factor: 2.183

10.  NOTCH1: Review of its role in lymphatic development and study of seven families with rare pathogenic variants.

Authors:  Sandro Michelini; Maurizio Ricci; Roberta Serrani; Shila Barati; Sercan Kenanoglu; Dominika Veselenyiova; Danjela Kurti; Mirko Baglivo; Syed Hussain Basha; Sasi Priya; Astrit Dautaj; Munis Dundar; Juraj Krajcovic; Matteo Bertelli
Journal:  Mol Genet Genomic Med       Date:  2020-11-28       Impact factor: 2.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.